New POCUS Scanner Available from FujiFilm
Sonosite PX improve image quality and workflow at the patient’s bedside.
Ultrasound vendor Fujifilm Healthcare has launched its latest point-of-care ultrasound system – Sonosite PX – that provides for better image quality, workflow efficiency improvements, and adaptability.
With a work surface that can be positioned both horizontally or vertically, the system adjusts to the exam at hand. It offers a smaller footprint for better bedside access, company officials said, and the height is adjustable, making it more ergonomic for the providers. Additionally, all patient information, worksheets, and reports that are pertinent to the exam at hand can be accessed in one location, and the system can link directly into the electronic health record.
SonoSite PX. Courtesy: FujiFilm Healthcare
To test the system’s durability, company officials said, they drop-tested Sonosite PX and its transducers to 1 meter. They also provided for greater cleaning and easier disinfection by sealing the system to the edge. And, among its functionalities, Sonosite PX offers two cardiac options that allow clinicians to choose between gathering targeted information about the heart to determine overall well-being or to examine specific cardiac conditions.
In addition, company leaders said, Sonosite PX augments the company's educational offerings with more than 140 onboard, 3D animation scan-along educational tutorials.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
